E62: Elizabeth Holmes verdict, fraud origins & takeaways, navigating "The Great Markdown" & more
All-In with Chamath, Jason, Sacks & Friedberg
00:00
The Blood Test Revolution: Trials and Tribulations
This chapter explores the ambitious claims of blood testing technology, specifically the potential of analyzing health data from a single drop of blood. It critically examines the Elizabeth Holmes case, highlighting the failures of transparency and due diligence among investors in the biotech sector. The discussion underscores the need for independent analysis in the investment community to avoid the pitfalls of hype-driven decision-making.
Transcript
Play full episode
